|
[Related PubMed/MEDLINE] Total Number of Papers: 5
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells. |
CAR, ccRCC, ICB, PBMCs, PD-L1 |
2 |
2016 |
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model. |
CAR, ccRCC, PD-L1 |
3 |
2014 |
Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model. |
111In, 177Lu, ccRCC, RIT |
4 |
2014 |
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma. |
RCC, TKIs |
5 |
2012 |
Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer. |
DTPA, HEPES, MES, SPECT |
|